发明名称 Method for treating systemic DNA mutation disease
摘要 The invention is directed to treatment of systemic DNA mutation diseases accompanied with development of somatic mosaicism and elevation of blood extracellular DNA. The inventive method comprises introducing a DNASE enzyme into the systemic blood circulation of a patient in doses and regimens which are sufficient to decrease average molecular weight of circulating extracellular blood DNA in the blood of said patient.
申请公布号 US8796004(B2) 申请公布日期 2014.08.05
申请号 US201313772499 申请日期 2013.02.21
申请人 CLS Therapeutics Limited 发明人 Genkin Dmitry Dmitrievich;Tets Georgy Viktorovich;Tets Viktor Veniaminovich
分类号 C12Q1/34;A61K38/46;C12N9/16;C07K14/00 主分类号 C12Q1/34
代理机构 Troutman Sanders LLP 代理人 Troutman Sanders LLP
主权项 1. A method for treating an acute ischemic condition of an organ which ischemic condition is caused by atherosclerosis in a patient in need thereof, wherein said method comprises introducing a DNase enzyme into the blood circulation of said patient, wherein said DNase enzyme is administered in a dose and regimen which is sufficient to decrease the average molecular weight of extracellular blood DNA in the blood of said patient as measured by gel electrophoresis of extracellular blood DNA fraction from the blood of said patient.
地址 Guernsey, Channels Islands GB